Shelf life (days): 1460.0
Formulation: A solid
Formal Name: N-(4-bromo-2-fluorophenyl)-6-methoxy-7-[2-(1H-1,2,3-triazol-1-yl)ethoxy]-4-quinazolinamine
Purity: ≥98%
Formula Markup: C19H16BrFN6O2
Formula Weight: 459.3
CAS Number: 413599-62-9
Notes: A VEGFR1, VEGFR2, and EGFR inhibitor (IC50s = 0.7, 0.03, and 0.4 µM, respectively); selective for these kinases over PDGFRβ, FGFR1, and HER2 (IC50s = 3.4, >100, and >100 µM, respectively) and MEK, Cdk2, IGF-1R, Akt, and Tie2 (IC50s = >10, >10, >20, >20, and >100 µM, respectively); selectively inhibits VEGF- or EGF-induced proliferation of HUVECs over FGF-induced proliferation of HUVECs (IC50s = 0.05, 0.05, and 1.5 µM, respectively); reduces tumor volume in a Calu-6 NSCLC mouse xenograft model at 100 mg/kg; inhibits training-induced increases in collateral blood flow and white gastrocnemius muscle capillarity in exercise-trained rats
Deutsch
English
